glp-1 and drinking alcohol reduction receptor agonists show promise in treating substance use disorders GLP-1 reduces heavy days – Alcohol and GLP‑1 medications: what

Both are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Affordability improvements may expand coverage: Frdric Leblanc, a pharmacist at iA Financial, notes that insurers are "preparing for everything we need to do so that everybody benefits from a lower price, both in diabetes and eventually in weight management." Sandoz CEO Richard Saynor has described Canada as the world's second-largest GLP-1 market

For some individuals with ASD, adhering to a GFD can lead to enhanced quality of life due to better health and symptom management

Trop Life Sci Res